Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis.


Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
28 02 2019
Historique:
received: 17 10 2017
revised: 25 09 2018
accepted: 27 09 2018
pubmed: 23 10 2018
medline: 2 5 2020
entrez: 23 10 2018
Statut: ppublish

Résumé

The use of the last observation carried forward (LOCF) method for imputing missing outcome data in randomized clinical trials has been much criticized and its shortcomings are well understood. However, only recently have published studies widely started using more appropriate imputation methods. Consequently, meta-analyses often include several studies reporting their results according to LOCF. The results from such meta-analyses are potentially biased and overprecise. We develop methods for estimating summary treatment effects for continuous outcomes in the presence of both missing and LOCF-imputed outcome data. Our target is the treatment effect if complete follow-up was obtained even if some participants drop out from the protocol treatment. We extend a previously developed meta-analysis model, which accounts for the uncertainty due to missing outcome data via an informative missingness parameter. The extended model includes an extra parameter that reflects the level of prior confidence in the appropriateness of the LOCF imputation scheme. Neither parameter can be informed by the data and we resort to expert opinion and sensitivity analysis. We illustrate the methodology using two meta-analyses of pharmacological interventions for depression.

Identifiants

pubmed: 30347460
doi: 10.1002/sim.8009
pmc: PMC6492186
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

720-737

Subventions

Organisme : Medical Research Council
ID : MC_UU_12023/21
Pays : United Kingdom

Informations de copyright

© 2018 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd.

Références

Clin Trials. 2007;4(2):125-39
pubmed: 17456512
Stat Med. 2015 Feb 28;34(5):742-52
pubmed: 25492741
Psychopharmacology (Berl). 2001 May;155(3):230-3
pubmed: 11432684
Evid Based Ment Health. 2014 May;17(2):53-7
pubmed: 24692250
J R Stat Soc Ser A Stat Soc. 2010 Jul;173(3):593-612
pubmed: 20711246
Res Synth Methods. 2012 Jun;3(2):80-97
pubmed: 26062083
CMAJ. 2008 Oct 7;179(8):751-3
pubmed: 18838445
Stat Med. 2008 Feb 28;27(5):728-45
pubmed: 17703502
Evid Based Ment Health. 2014 Aug;17(3):85-9
pubmed: 25009175
Stata J. 2018 Jul 1;18(3):716-740
pubmed: 30595674
N Engl J Med. 2003 May 22;348(21):2136-7
pubmed: 12761370
J Biopharm Stat. 2009 Sep;19(5):872-88
pubmed: 20183449
Lancet. 2018 Apr 7;391(10128):1357-1366
pubmed: 29477251
N Engl J Med. 2012 Oct 4;367(14):1355-60
pubmed: 23034025
Stat Med. 2019 Feb 28;38(5):720-737
pubmed: 30347460
Lancet. 2016 Nov 19;388(10059):2492-2500
pubmed: 27789061
Clin Trials. 2004;1(6):477-89
pubmed: 16279288
Stat Med. 2008 Feb 28;27(5):711-27
pubmed: 17703496
Stat Med. 2015 Feb 28;34(5):721-41
pubmed: 25393541
Res Synth Methods. 2015 Jun;6(2):175-87
pubmed: 26099485
Biostatistics. 2004 Jul;5(3):445-64
pubmed: 15208205

Auteurs

Dimitris Mavridis (D)

Department of Primary Education, University of Ioannina, Ioannina, Greece.

Georgia Salanti (G)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Toshi A Furukawa (TA)

Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Andrea Cipriani (A)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Anna Chaimani (A)

Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS-UMR1153), Inserm/Université Paris Descartes, Paris, France.

Ian R White (IR)

MRC Clinical Trials Unit, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH